Immunocore
Kabir Hussain is a Principal Scientist I at Immunocore since May 2024, with prior experience as a Principal Scientist and Senior Translational Scientist at Evox Therapeutics Ltd from September 2021 to May 2024, and as a Senior Scientist at Immunocore from July 2017 to September 2021. Hussain has a strong background in bioanalytical assay development and validation, with a focus on supporting clinical studies and drug pipeline advancements. Previous roles include Scientific Project Lead II at Eurofins, where method development and validation were central responsibilities, and Associate Scientist 1 at MedImmune, specializing in Immunoassay development for PK/PD and ADA assessments. Early experience as an Experimental Officer at Covance involved routine sample analysis and method validations. Kabir Hussain holds a BSc in Cancer Biology and Immunology from the University of Bristol, completed in 2007.
This person is not in any teams
Immunocore
1 followers
Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.